Providing financial assistance to patients has become a common refrain in drugmakers’ defense of high-priced drugs.
4 Industry Execs Examine the State of Physician-Rep Access
February 3, 2016
10:06 pm
Recent polls paint a mixed picture of physicians’ willingness to see pharma sales reps. What gives? Are no-see docs up or down, and what’s behind the dissonant findings?
At Work With: Fingerpaint’s Joe Acee
January 21, 2016
9:36 pm
“A global launch of a type-2 diabetes drug. It was a four-year trail of cheers and tears.”
The kits aren’t likely to enhance American Girl’s bottom line in any significant way, yet the flood of press coverage painted the company as compassionate in a way that few such organizations are.